Singular Genomics Systems, Inc.
OMICDelisted Feb 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850906
Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Singular Genomics Systems, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −1 vs. Q2 2024
- Shares held
- 1.17M
- +485.6K (+70.4%) vs. Q2 2024
- Total value
- $18.4M
- +$12.6M (+216.0%) vs. Q2 2024
- New holders
- 4
- 4 more added
- Sold out
- 5
- 4 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OMIC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $512.7K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 20 | $21.5M |
| Q3 2024 | 22 | $18.4M |
| Q2 2024 | 24 | $6.00M |
| Q1 2024 | 42 | $13.1M |
| Q4 2023 | 47 | $12.1M |
| Q3 2023 | 48 | $10.6M |
| Q2 2023 | 62 | $27.3M |
| Q1 2023 | 66 | $43.4M |
| Q4 2022 | 81 | $74.8M |
| Q3 2022 | 74 | $100.5M |
| Q2 2022 | 76 | $149.1M |
| Q1 2022 | 69 | $258.7M |
| Q4 2021 | 62 | $450.2M |
| Q3 2021 | 52 | $312.4M |
| Q2 2021 | 52 | $757.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Singular Genomics Systems, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 372,000 | $5.83M | 0.42% | +372,000 | New |
| Deerfield Management Company, L.P. (Series C) | 166,162 | $2.60M | 0.04% | 00.0% | Unchanged |
| ARCH Venture Management, LLC | 126,630 | $1.98M | 0.76% | 00.0% | Unchanged |
| CRCM LP | 101,100 | $1.58M | 1.03% | +101,100 | New |
| QVIDTVM Management LLC | 83,558 | $1.31M | 0.92% | 00.0% | Unchanged |
| UBS Group AG | 77,984 | $1.22M | 0.00% | +77,984 | New |
| FMR LLC | 70,653 | $1.11M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 62,418 | $978.1K | 0.00% | +10.0% | Added |
| Perceptive Advisors LLC | 50,896 | $797.5K | 0.02% | −20,000−28.2% | Reduced |
| Geode Capital Management, LLC | 17,962 | $281.5K | 0.00% | +1,193+7.1% | Added |
| HighTower Advisors, LLC | 17,607 | $276.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 15,734 | $246.6K | 0.00% | +15,734 | New |
| Tikvah Management LLC | 10,561 | $165.5K | 0.05% | 00.0% | Unchanged |
| Barclays PLC | 409 | $6.41K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 369 | $5.78K | 0.00% | +2+0.5% | Added |
| Morgan Stanley | 307 | $4.81K | 0.00% | −56−15.4% | Reduced |
| Tower Research Capital LLC (TRC) | 281 | $4.40K | 0.00% | −247−46.8% | Reduced |
| JPMorgan Chase & Co | 180 | $2.82K | 0.00% | +160+800.0% | Added |
| Royal Bank of Canada | 67 | $1.00K | 0.00% | −20−23.0% | Reduced |
| Dynamic Wealth Strategies, LLC | 56 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 36 | $564 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 5 | $78 | 0.00% | 00.0% | Unchanged |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −44,129−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −18,023−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −55−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |